{"name":"Minovia Therapeutics Ltd.","slug":"minovia-therapeutics-ltd","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiowFBVV95cUxQQWF4bjBGZURZNXMyM2dVMGl2eURNclVlcUFjbFpxXy1TLV9mb0Myc1lhTFlUVG9lSm1YaEd5bkFSN3dReGtLRkFGaHdWQ3EtQWNYTzJOTnNOSFlSTVE2UVF4LXNab0s2V1ZtVzl4WHBpN2ctY0lQVGhBQUFCb1JtM1IySjFmaDlLQ2ZCYVhfQms5RTIzVXo2RXA4R2plVF9mYlBF?oc=5","date":"2025-11-04","type":"regulatory","source":"Oncology News Central","summary":"Oncology Drugs Fast-Tracked by the FDA in October 2025 - Oncology News Central","headline":"Oncology Drugs Fast-Tracked by the FDA in October 2025","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipwFBVV95cUxPTFYzVjdTejhSdDgzekZyaGdfUlFRWTBnYUh4RXFZVzlCci15NWNKMmp2Rk5IZ0FxYU9FWllkczhQRnpKei1USk5reDhTMEZGMDJVM2ZscnpIU1Rkc2JXOVQ5UFNza3dLUHFEZE5FZEliZE8xZ3dEbzRPWWVSLWEwV2hRUXVSMzBfa1loMkdRLWhvZk1MTlNLWkRCZUE1d0Vuek41cDU0bw?oc=5","date":"2025-10-07","type":"regulatory","source":"Oncology News Central","summary":"Oncology Drugs Granted FDA Designations in September 2025 - Oncology News Central","headline":"Oncology Drugs Granted FDA Designations in September 2025","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiogJBVV95cUxORWVhbzRuRkdhaExOM1Q3NmdFa29UM0ZKUGIzUGp6Nk80TEM2U1MxM2VuRkV2U3RhSmpmc0VSOWpyNlIwYWRsYmg5X1lobTI5bjlOcUZ5akl5SG50NkdEYkVqSEdSNUdiY3hKUm1WQV9DZUQzU3RqTUtmTE5pQnhVM0xpN1FNR0RPN3loUVltZlZlQnZrM2sxdHhvQk1aVmZVY21SZUpTZlNYQVFDbkVkTF9Tc2hMb3pXbzRGVDY0akM3NzJhRFFuVDd0WmdSVzlwYlFLU09sNFNLVEdDLWRZdWJ0YnN6M0h3c25ScEpNbUk4ZllhSzFZeUR0Q3JMbU1FZ3dQeE12T0pXZ1JVUkNnU2ZNcHpMd3VJM3JfcFllN1d4UQ?oc=5","date":"2025-08-27","type":"pipeline","source":"GlobeNewswire","summary":"Countdown For A Cure Awards $350,000 Grant to Minovia - GlobeNewswire","headline":"Countdown For A Cure Awards $350,000 Grant to Minovia","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilwFBVV95cUxOSm85U05Hc3g2bkdvNi03WUk2eFRZQnNEMXhGVlZZb2F6OS11bV9MOTNXU1FkTmIwOXM3djFvY2ZWY2pQY2pzaDd6N1lpeVNGTVpKTFlldkVIN29ubWM4SnJ5YjJjUkV4YVBsMS1ELWRhdV9nV2hCVllhcVZJTDBFb1A3Zk45ZkhMZVVUWTlsN3AtdzVwbU1j?oc=5","date":"2025-06-25","type":"pipeline","source":"Fierce Biotech","summary":"Minovia brings back SPAC with plans to skate into icy public market - Fierce Biotech","headline":"Minovia brings back SPAC with plans to skate into icy public market","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi0wFBVV95cUxQOWNpcnBoZ0RIeGpaem1xemxXMC1UTVZNLXNYSHZzempyYmQxWXY4SmxwVmo5TEtVMkRVSU1QbVF0c2duUzM0VXZZZVlVTWVXdkxiSnI2UkVwV29oMVRIWW5nTG9KS2RyaDctd1U5VEJyVkN6ajA5REZaMzZTRjhNLVFnUTVnQU1MVVNqaVBFdlA2dU93VVpDWk5SVkJIQV9XTlZBTnBfYks3UWNrMTZRV0JhQ1NDTzB0cFI4akZrS1lEWlgxOXFtRkZXRjBMQjdJd1hn?oc=5","date":"2025-04-10","type":"pipeline","source":"Inside Precision Medicine","summary":"Pretzel Therapeutics Reveals Novel mtDNA Deficiency Syndrome Drugs - Inside Precision Medicine","headline":"Pretzel Therapeutics Reveals Novel mtDNA Deficiency Syndrome Drugs","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi_wFBVV95cUxQRWRoUDY4OVNSLVU1T2FRWTh4Zl90aUtINHZGSnRRRVpwRkdmTjlNMWlsNmRKUGw5NTczbk9IWGlPWGhrYnJZcWwxVjZUeTJWT0R1OXItc0pIY3M4MGU4QV9mcHpLckUwRVdYQjNyUDkwa05OOXZfeU1QUXFGWkpTeGRSU0thU0xGOFo1aDFpR0g3a1pvUHlUTjRfSGdyWVdOOGZPdWhRcWRzd1Mwd2xSbnlMeGYzS2RPSHVSckhqM2U5RC04NTBzNE1DVFNBNGhqazZya3IxdHFkMnhKcGEtaWRWSFZzbFhldDM1clU0Si1KaUJoNHEzQ2hIYkNJcmM?oc=5","date":"2024-09-27","type":"regulatory","source":"BioPharma APAC","summary":"Minovia Therapeutics Receives FDA Clearance to Initiate Phase Ib Trial for Mitochondrial Cell Therapy in Low-Risk MDS Patients - BioPharma APAC","headline":"Minovia Therapeutics Receives FDA Clearance to Initiate Phase Ib Trial for Mitochondrial Cell Therapy in Low-Risk MDS Pa","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiakFVX3lxTE94bTdxWkZRbU5tMnplVy05RzdsVS1hSXVGNHExSk04bFl2TGtVbE9DcEFIaTdhandRc2Yyb3F3VU5yNk9LZk5yNHFFU3VUeERvN21STW1BdElIR2poUl9nZ0ttUFQ3RjVnU3c?oc=5","date":"2022-07-20","type":"pipeline","source":"Wiley Online Library","summary":"Qualitative exploration of the lived experience of adults diagnosed with primary mitochondrial disease - Wiley Online Library","headline":"Qualitative exploration of the lived experience of adults diagnosed with primary mitochondrial disease","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiakFVX3lxTE5oQWd4T1B3cTM3TWF5anU3SS1IN0Z1YXpZU093aldwbWpqN2djZEVaWDdrdzkya3g3SndqVXlndlVWOWVCOV9OdUpEbFFPb2h4TVl4SDlmSV9nS2NpTDEybzdqWUdKamRmYWc?oc=5","date":"2022-03-06","type":"pipeline","source":"Sage Journals","summary":"Astellas Weighs Move into Exosomes: - Sage Journals","headline":"Astellas Weighs Move into Exosomes:","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi_gFBVV95cUxNSkF5S19CMzVXTEFDOFVfdm1FMndRWl9hemhwNnZoUmpmY1R2Xy1pcnRrU2I1Z2pTczFadFlpRGhTbTVpcXBQMG5ZTk5Ha3gxMXQ2U1h1MHM1Zy1HT2pxUFRHNnpjOTVoOHNCT3lsTUZRVGpSeFY5MXBSa3A2X1A0emx1eV9TeXpfd0ZVX09ZS1dBRmpYZFotS25RMEdGUFFzemtqTDdXS09kbDRBZndtRDl3OFV6d05TLXhyYWQ5MjhkLXNVbVRNcnpvbEJqTFc4bzN1U1dELXhwbkoxdjFoQjNEVGpHbFAtQUNSNnpaMHhFWm5CN0E4dk50M0c1dw?oc=5","date":"2021-07-30","type":"deal","source":"Business Wire","summary":"Astellas and Minovia Therapeutics Announce Strategic Collaboration for Novel Mitochondrial Cell Therapy Programs - Business Wire","headline":"Astellas and Minovia Therapeutics Announce Strategic Collaboration for Novel Mitochondrial Cell Therapy Programs","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}